Toxic Effects of Amanitins: Repurposing Toxicities toward New Therapeutics - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Toxins Année : 2021

Toxic Effects of Amanitins: Repurposing Toxicities toward New Therapeutics

Résumé

The consumption of mushrooms has become increasingly popular, partly due to their nutritional and medicinal properties. This has increased the risk of confusion during picking, and thus of intoxication. In France, about 1300 cases of intoxication are observed each year, with deaths being mostly attributed to Amanita phalloides poisoning. Among amatoxins, alpha- and beta-amanitins are the most widely studied toxins. Hepatotoxicity is the hallmark of these compounds, leading to hepatocellular failure within three days of ingestion. The toxic mechanisms of action mainly include RNA polymerase II inhibition and oxidative stress generation, leading to hepatic cell apoptosis or necrosis depending on the doses ingested. Currently, there is no international consensus concerning Amanita phalloides poisoning management. However, antidotes with antioxidant properties remain the most effective therapeutics to date suggesting the predominant role of oxidative stress in the pathophysiology. The partially elucidated mechanisms of action may reveal a suitable target for the development of an antidote. The aim of this review is to present an overview of the knowledge on amanitins, including the latest advances that could allow the proposal of new innovative and effective therapeutics.
Fichier principal
Vignette du fichier
toxins-13-00417.pdf (1.32 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03281620 , version 1 (08-07-2021)

Licence

Paternité

Identifiants

Citer

Brendan Le Dare, Pierre-Jean Ferron, Thomas Gicquel. Toxic Effects of Amanitins: Repurposing Toxicities toward New Therapeutics. Toxins, 2021, 13 (6), pp.417. ⟨10.3390/toxins13060417⟩. ⟨hal-03281620⟩
42 Consultations
173 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More